Skip to main content

ACT-HIB haemophilus type B conjugate vaccine (conjugated to tetanus protein) powder for injection vial and diluent syringe (2023-24)

Product name
ACT-HIB haemophilus type B conjugate vaccine (conjugated to tetanus protein) powder for injection vial and diluent syringe
Sponsor name
Sanofi-Aventis Australia Pty Ltd
ARTG
43725
Year Range
2023-24

Help us improve the Therapeutic Goods Administration site